Adapting decarbonylation chemistry for the development of prodrugs capable of in vivo delivery of carbon monoxide utilizing sweeteners as carrier molecules-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Adapting decarbonylation chemistry for the development of prodrugs capable of in vivo delivery of carbon monoxide utilizing sweeteners as carrier molecules

Published:2021 Issue:31 Volume:12 Page:10649-10654
ISSN:2041-6520
Container-title:Chemical Science
language:en
Short-container-title:Chem. Sci.

Author:

De La Cruz Ladie Kimberly¹²³⁴,Yang Xiaoxiao¹²³⁴,Menshikh Anna⁵⁶⁷⁸⁴,Brewer Maya⁵⁶⁷⁸⁴,Lu Wen¹²³⁴,Wang Minjia⁹¹⁰⁴,Wang Siming¹²³⁴,Ji Xingyue¹²³⁴,Cachuela Alyssa¹²³⁴,Yang Haichun¹¹⁷⁸⁴,Gallo David¹²¹³¹⁴¹⁵⁴,Tan Chalet⁹¹⁰⁴,Otterbein Leo¹²¹³¹⁴¹⁵⁴,de Caestecker Mark⁵⁶⁷⁸⁴,Wang Binghe¹²³⁴^ORCID

Affiliation:

1. Department of Chemistry

2. Georgia State University

3. Atlanta

4. USA

5. Department of Medicine

6. Division of Nephrology

7. Vanderbilt University Medical Center

8. Nashville

9. Department of Pharmaceutics and Drug Delivery

10. University of Mississippi

11. Department of Pathology, Microbiology, and Immunology

12. Department of Surgery

13. Beth Israel Deaconess Medical Center

14. Harvard Medical School

15. Boston

Abstract

1,2-Dicarbonyl compounds with FDA-approved sweeteners as leaving groups deliver CO for protection against acute kidney injury in mice.

Funder

National Institutes of Health

Georgia Research Alliance

Georgia State University

Department of Defense

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2021/SC/D1SC02711E

Reference62 articles.

1. The therapeutic potential of carbon monoxide

2. Carbon Monoxide: Endogenous Production, Physiological Functions, and Pharmacological Applications

3. Nature's marvels endowed in gaseous molecules I: Carbon monoxide and its physiological and therapeutic roles

4. Role of Carbon Monoxide in Kidney Function: Is a little Carbon Monoxide Good for the Kidney?

5. Carbon monoxide: An emerging therapy for acute kidney injury

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemical Strategies Toward Prodrugs and Fluorescent Probes for Gasotransmitters;Mini-Reviews in Medicinal Chemistry;2024-02

2. Reactive Oxygen Species-Activated Metal-Free Carbon Monoxide Prodrugs for Targeted Cancer Treatment;Journal of Medicinal Chemistry;2023-11-01

3. Plight of CORMs: The unreliability of four commercially available CO-releasing molecules, CORM-2, CORM-3, CORM-A1, and CORM-401, in studying CO biology;Biochemical Pharmacology;2023-08

4. Toward “CO in a Pill”: Silica-Immobilized Organic CO Prodrugs for Studying the Feasibility of Systemic Delivery of CO via In Situ Gastrointestinal CO Release;Molecular Pharmaceutics;2023-02-20

5. Reassessing CORM-A1: redox chemistry and idiosyncratic CO-releasing characteristics of the widely used carbon monoxide donor;Chemical Science;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3